Mao et al. demonstrated that the CD8+ T cell-derived exosome miR-2682 inhibited lung cancer tumor formation, whereas the CAF-derived exosome FOXD3-AS1 promoted lung cancer tumor formation [163]. The gene discussed is CD8A; the disease is lung carcinoma.